VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,591,000 | -10.6% | 59,123 | 0.0% | 1.92% | -5.3% |
| Q2 2023 | $1,780,194 | -6.9% | 59,123 | 0.0% | 2.03% | +5.6% |
| Q1 2023 | $1,912,629 | +12.9% | 59,123 | 0.0% | 1.92% | +66.0% |
| Q4 2022 | $1,694,465 | +19.1% | 59,123 | +0.2% | 1.16% | -36.3% |
| Q3 2022 | $1,423,000 | -11.9% | 59,014 | 0.0% | 1.82% | -3.0% |
| Q2 2022 | $1,616,000 | -28.6% | 59,014 | 0.0% | 1.87% | -17.6% |
| Q1 2022 | $2,263,000 | +19.7% | 59,014 | 0.0% | 2.27% | +334.6% |
| Q4 2021 | $1,890,000 | +8.9% | 59,014 | +0.2% | 0.52% | -2.4% |
| Q3 2021 | $1,735,000 | -13.2% | 58,872 | 0.0% | 0.54% | -26.1% |
| Q2 2021 | $2,000,000 | +4.8% | 58,872 | +0.3% | 0.72% | +13.6% |
| Q1 2021 | $1,908,000 | -9.7% | 58,703 | 0.0% | 0.64% | -38.7% |
| Q4 2020 | $2,114,000 | -7.9% | 58,703 | +0.2% | 1.04% | +33.2% |
| Q3 2020 | $2,295,000 | +7.0% | 58,613 | +0.2% | 0.78% | -48.3% |
| Q2 2020 | $2,145,000 | +59.2% | 58,476 | 0.0% | 1.51% | +19.7% |
| Q1 2020 | $1,347,000 | -21.3% | 58,476 | 0.0% | 1.26% | -46.0% |
| Q4 2019 | $1,712,000 | +9.6% | 58,476 | 0.0% | 2.34% | +307.9% |
| Q3 2019 | $1,562,000 | +4.5% | 58,476 | 0.0% | 0.57% | +12.4% |
| Q2 2019 | $1,495,000 | +13.2% | 58,476 | -0.7% | 0.51% | -21.3% |
| Q1 2019 | $1,321,000 | +5.1% | 58,907 | -1.1% | 0.65% | -17.0% |
| Q4 2018 | $1,257,000 | +12.6% | 59,578 | -1.2% | 0.78% | +42.8% |
| Q3 2018 | $1,116,000 | -17.0% | 60,281 | 0.0% | 0.55% | -28.3% |
| Q2 2018 | $1,345,000 | +1.5% | 60,281 | 0.0% | 0.76% | +19.2% |
| Q1 2018 | $1,325,000 | -5.4% | 60,281 | 0.0% | 0.64% | +47.8% |
| Q4 2017 | $1,401,000 | +3.5% | 60,281 | +2.2% | 0.43% | +18.3% |
| Q3 2017 | $1,354,000 | +1.4% | 58,993 | -2.5% | 0.37% | +5.2% |
| Q2 2017 | $1,335,000 | -3.2% | 60,476 | 0.0% | 0.35% | -16.5% |
| Q1 2017 | $1,379,000 | +16.1% | 60,476 | +6.5% | 0.42% | +6.1% |
| Q4 2016 | $1,188,000 | -15.9% | 56,767 | +6.2% | 0.39% | -26.3% |
| Q3 2016 | $1,413,000 | -4.7% | 53,472 | 0.0% | 0.53% | -7.0% |
| Q2 2016 | $1,482,000 | – | 53,472 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |